Medical News

RSS

FDA-approved contrast agent improves optical imaging of stem cells

A study published in the current issue of Cell Transplantation (19:1) has found that using the FDA-approved contrast agent Indocyanine Green (ICG) to label human embryonic stem cell-derived cardiomyocytes (hESC-CMs) substantially improved efforts to optically track stem cells after transplanting them into heart tissues.

6 Apr 2010

SCYNEXIS' SCY-635 inhibitor abstracts accepted for presentation at EASL Annual Meeting

Drug discovery company, SCYNEXIS, Inc. today announced that multiple abstracts related to the Company's cyclophilin inhibitor, SCY-635, were accepted for presentation at the 45th Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria, April 14-18, 2010.

6 Apr 2010

Older riders more likely to die from motorcycle accidents

Motorcycle riders across the country are growing older, and the impact of this trend is evident in emergency rooms daily. Doctors are finding that these aging road warriors are more likely to be injured or die as a result of a motorcycle mishap compared to their younger counterparts.

6 Apr 2010

Prescription drug abuse reaches epidemic proportions

Poisoning is now the second leading cause of unintentional injury death in the U.S. While several recent high-profile Hollywood celebrity cases have brought the problem to public attention, the rates of unintentional poisoning deaths have been on the rise for more than 15 years.

6 Apr 2010

Web-based version of Point of Care Guidelines launched

The Clinical Practice Model Resource Center, an Elsevier company and leader in developing clinical practice guidelines for healthcare, today launched its first Web-based version of Point of Care Guidelines(TM).

6 Apr 2010

Older Americans susceptible to fatal injuries

The risk of dying from injuries is increasing for Americans ages 65 and older according to a new report from the Johns Hopkins Bloomberg School of Public Health's Center for Injury Research and Policy.

6 Apr 2010

Officials focus on inequalities in medical research

"After years of individual cancer centers exploring ways to recruit more people from minority populations for cancer studies, $3.8 million in federal stimulus money has been awarded to five institutions — including M.D. Anderson (Cancer Center at the University of Texas) — to work on the issue together for the next two years. The National Center on Minority Health and Health Disparities, part of the National Institutes of Health, funded the project."

6 Apr 2010

Exposure to certain chemicals may lead to early pubertal development

Researchers at Mount Sinai School of Medicine have found that exposure to three common chemical classes-phenols, phthalates and phytoestrogens-in young girls may disrupt the timing of pubertal development, and put girls at risk for health complications later in life.

6 Apr 2010

Unilife's Unitract 1mL Insulin Syringes receive 510(k) market clearance

Unilife Corporation today announced it has received from the U.S. Food and Drug Administration 510(k) market clearance for the Unitract™ 1mL Insulin Syringes assembled at its Lewisberry, PA manufacturing facility.

6 Apr 2010

World Health Day to focus on making cities healthier

As part of this year's World Health Day, the WHO on Wednesday will launch a program to encourage cities to become more healthy to help mitigate the health risks associated with rapid urbanization, Agence France Presse/Inquirer.net Global Nation reports.

6 Apr 2010

Rice University's nano-bio-chip 93% specific in detecting patients with premalignant lesions

The gentle touch of a lesion on the tongue or cheek with a brush can help detect oral cancer with success rates comparable to more invasive techniques, according to preliminary studies by researchers at Rice University, the University of Texas Health Science Centers at Houston and San Antonio and the University of Texas M.D. Anderson Cancer Center.

6 Apr 2010

Ardea Biosciences proposes underwritten public offering of common stock

Ardea Biosciences, Inc. today announced that it is offering to sell shares of its common stock in an underwritten public offering. Jefferies & Company, Inc. is acting as sole book-running manager in this offering.

6 Apr 2010

Some Democrats facing resistance at home - from both sides - for health reform votes

Rep. Betsy Markey, D-Colo., "a first-term Democrat in a Republican district, was one of just eight House members who switched their votes from 'no' to 'yes' when President Obama's health-care bill finally passed Congress.

6 Apr 2010

APHA survey: 85% Americans are taking steps towards healthier living

Eighty-five percent of Americans characterize their lifestyle as somewhat or very healthy, according to a survey released today by the American Public Health Association.

6 Apr 2010

Cephalon acquires biotechnology company, Ception Therapeutics

Cephalon, Inc. announced today that it has completed its previously announced acquisition of biotechnology company Ception Therapeutics, Inc. and that Ception is now a wholly-owned subsidiary of Cephalon.

6 Apr 2010

Barrow Neurological Institute scientist receives grant to study myasthenia gravis

A scientist at Barrow Neurological Institute in Phoenix has been awarded a major grant from the Muscular Dystrophy Association to continue his groundbreaking work in the disease of myasthenia gravis.

6 Apr 2010

Dalfampridine drug for multiple sclerosis now available in the U.S.

A drug whose clinical benefit in treating multiple sclerosis was discovered at Rush University Medical Center was approved by the Food and Drug Administration on January 22 and is now available in the U.S.

6 Apr 2010

New formulation of controlled-release drug OxyContin approved

The U.S. Food and Drug Administration today approved a new formulation of the controlled-release drug OxyContin that has been designed to help discourage misuse and abuse of the medication.

6 Apr 2010

Health IT funding raises security concerns; Some hospitals face barrier to funding

"Two big questions yet to be answered with electronic health records are: Do they save money? And can they be made 100 percent secure? The verdict is still out on both. The thought of one's personal medical information being just a computer click away does not sit well with many consumers." The paper reviews several surveys from last year to note that "security is on everyone's mind" (Smith, 4/5).

6 Apr 2010

Chinese SFDA approves Erye Pharmaceutical to manufacture generic Cloxapen

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced that its Suzhou Erye Pharmaceutical subsidiary ("Erye") recently received approval from the State Food and Drug Administration (SFDA) in China to manufacture the sterile active pharmaceutical ingredient (API) of the anti-infective cloxacillin sodium.

5 Apr 2010